Paradigm Biocapital Advisors LP

Holdings History for PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX)

Symbol: PLRX on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 0 shares
Security Ownership %: 0%

Shares, Excluding Options vs Price

Value, Excluding Options

Paradigm BioCapital Advisors LP ownership in PLIANT THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (PLRX)

15 May 2025 - Paradigm BioCapital Advisors LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of PLIANT THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (PLRX). This represents 0% ownership of the company. This is the first filing by Paradigm Biocapital Advisors LP disclosing ownership of PLIANT THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (PLRX).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Paradigm BioCapital Advisors LP	0%		$0	0			$1.26	13G/A	31 Mar 2025	15 May 2025, 16:39

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Mar 2025		-1.5%	$0	0	-3,197,050	-100%		Q1 2025
31 Dec 2024	1.5%	+0.04%	$42,105,149	3,197,050	+92,564	+3%	$13.17	Q4 2024
30 Sep 2024	1.2%	+1.2%	$34,801,288	3,104,486	+3,104,486	NEW	$11.21	Q3 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.